Warning Letter – Michigan Instruments Inc.

Company: Michigan Instruments Inc.
Product: Thumper Model 1007 Mechanical CPR System
Date: 3/23/04

You failed to perform or document the verification or validation of production process changes, such as the Inspiratory Time Test Specification, _____ on 12/17/2002 and the _____ software changes on 11/7/2000 (FDA-483 #11, c. and # 11, i) as required by 21 CFR 820.7(b).

You failed to validate the computer software, and all subsequent changes to this software, used in the operation of automated production machinery (FDA-483 # 18), as required by 21 CFR 820.70(i).

You failed to retain records for a period of time equivalent to the design and expected life of the device, but in no case less than 2 years from the date of release for commercial distribution by the manufacturer, as required by 21 CFR 820.180(b). Specifically, you failed to retain portions of the Device Master Records, consisting of early versions of computer software, following revisions to that software (FDA-483 # 19).

You failed to establish and maintain procedures to ensure that sampling methods are adequate for their intended use. Specifically, you failed to document the procedures used to ensure the adequacy of the selected sampling plan used in the verification of the computer software used with the _____ machine (FDA-483 # 20) as required by 21 CFR 820.250(b).

You have failed to establish and follow procedures to monitor and control production processes (FDA-483 # 16) as required by 21 CFR 820,70(a)(2). For example, the 95 specifications listed in the “unapproved” computerized Process Control Data and the CNC Program Validation forms for the machining of the _____ have not been formally established into a monitoring and controlling procedure. This resulted in the failure to fully monitor and control production of three lots of _____ as listed in the referenced FDA-483 # 16 observation

You failed to maintain Device Master Records. Specifically, some of your Device Master Records (DMR’s) do not include or refer to the location of production and process specifications (FDA-483 # 14) as required by 21 CFR 820.181(b) For example, the portion of the DMR “approved” on 4/21/00 for producing the _____ on the _____ machine, lacks any specifications while an “unapproved” computer generated specification sheet lists 95 specifications.

However, it is our perception that the blank SIR and Flow Chart forms were designed for check in a box or short answers that are to be entered into the computerized system that provides very limited space for detailed answers. This appears to have caused inappropriate or insufficient detail in entries that failed to fully document the decision making process required to comply with the regulations. You need to make sure your records system provides instructions for and adequate space for entry of complete documentation of the decision process.

FDA District: Detroit District Office

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

Being Agile & Yet Compliant (Public)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.

Lead Instructor: Mike Russell

Next public offerings:

  • Americas: 11-13 February 2025
  • EU/Eastern Europe/Middle East/Africa/Atlantic/eastern South America: 18-20 February 2025
  • Southern Central Northeastern Pacific: 24-26 February 2025
See our post titled: 1st Quarter 2025 Agile Compliant Courses Scheduled

 

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Call or email now to schedule a private, in-house class. The fall schedule is filling up!

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.